|
Volumn 12, Issue 13, 2002, Pages 1719-1722
|
Pyrrolidine-5,5-trans-lactams as novel mechanism-based inhibitors of human cytomegalovirus protease. Part 3: Potency and plasma stability
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ENZYME INHIBITOR;
LACTAM DERIVATIVE;
PROTEINASE;
VIRUS ENZYME;
ANTIVIRUS AGENT;
DANSYL CHLORIDE;
DANSYLPROLINE;
DRUG DERIVATIVE;
LACTAM;
PROLINE;
PROTEINASE INHIBITOR;
PYRROLIDINE DERIVATIVE;
ARTICLE;
CHEMICAL STRUCTURE;
DRUG MECHANISM;
DRUG POTENCY;
DRUG STABILITY;
HUMAN CYTOMEGALOVIRUS;
PLASMA;
BLOOD;
CHEMISTRY;
CYTOMEGALOVIRUS;
ELECTROSPRAY MASS SPECTROMETRY;
ENZYMOLOGY;
HALF LIFE TIME;
HUMAN;
IC 50;
ANTIVIRAL AGENTS;
CYTOMEGALOVIRUS;
DANSYL COMPOUNDS;
DRUG STABILITY;
HALF-LIFE;
HUMAN;
INHIBITORY CONCENTRATION 50;
LACTAMS;
PROLINE;
PROTEASE INHIBITORS;
PYRROLIDINES;
SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;
HUMANS;
CYTOMEGALOVIRUS;
HUMAN HERPESVIRUS 5;
|
EID: 0037042763
PISSN: 0960894X
EISSN: None
Source Type: Journal
DOI: 10.1016/S0960-894X(02)00294-9 Document Type: Article |
Times cited : (29)
|
References (9)
|